279 related articles for article (PubMed ID: 9017770)
81. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension.
Saseen JJ; Carter BL; Brown TE; Elliott WJ; Black HR
Hypertension; 1996 Jul; 28(1):109-14. PubMed ID: 8675249
[TBL] [Abstract][Full Text] [Related]
82. Effects of antihypertensive therapy on platelet cytosolic calcium responses to low density lipoprotein cholesterol.
Sowers JR; Raman BB; Afonso LC; Bedford-Rice K; Standley PR
J Hum Hypertens; 1996 Mar; 10(3):177-80. PubMed ID: 8733036
[TBL] [Abstract][Full Text] [Related]
83. Change in cough reflex after treatment with enalapril and ramipril.
McEwan JR; Choudry N; Street R; Fuller RW
BMJ; 1989 Jul; 299(6690):13-6. PubMed ID: 2547470
[TBL] [Abstract][Full Text] [Related]
84. [Delayed-action calcium antagonists and therapy of arterial hypertension].
da Costa JN
Rev Port Cardiol; 1992; 11(7-8):617-21. PubMed ID: 1389299
[TBL] [Abstract][Full Text] [Related]
85. Comparison of clinical efficacy and adverse effects between extended-release felodipine and slow-release diltiazem in patients with isolated systolic hypertension.
Chern MS; Lin FC; Wu D
Changgeng Yi Xue Za Zhi; 1999 Mar; 22(1):44-51. PubMed ID: 10418209
[TBL] [Abstract][Full Text] [Related]
86. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group.
Ollivier JP; Wajman A; Stalla-Bourdillon A
Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759
[TBL] [Abstract][Full Text] [Related]
87. Individual responses to converting enzyme inhibitors and calcium antagonists.
Bidiville J; Nussberger J; Waeber G; Porchet M; Waeber B; Brunner HR
Hypertension; 1988 Feb; 11(2):166-73. PubMed ID: 2830189
[TBL] [Abstract][Full Text] [Related]
88. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension.
Wells T; Frame V; Soffer B; Shaw W; Zhang Z; Herrera P; Shahinfar S;
J Clin Pharmacol; 2002 Aug; 42(8):870-80. PubMed ID: 12162469
[TBL] [Abstract][Full Text] [Related]
89. Comparative efficacy and safety of enalapril and sustained-release nifedipine in patients with mild to moderate hypertension. The Enalapril vs Nifedipine French Study Group.
Gueret P; Artigou JY; Benichou M; Berland J; Fressinaud P; Grollier G; Nguyen CD
Drugs; 1990; 39 Suppl 2():67-72. PubMed ID: 2188826
[TBL] [Abstract][Full Text] [Related]
90. [Comparative assessment of a calcium antagonist with controlled release of nifedipine and enalapril in arterial hypertension in subjects older than 60 years].
Oleĭnikov VE; Grishaeva EE; Borisova NA; Iastrebova EI; Fadeeva SS
Kardiologiia; 2009; 49(5):34-9. PubMed ID: 19463133
[TBL] [Abstract][Full Text] [Related]
91. Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trail.
Brozena SC; Johnson MR; Ventura H; Hobbs R; Miller L; Olivari MT; Clemson B; Bourge R; Quigg R; Mills RM; Naftel D
J Am Coll Cardiol; 1996 Jun; 27(7):1707-12. PubMed ID: 8636558
[TBL] [Abstract][Full Text] [Related]
92. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension.
Sakata K; Shirotani M; Yoshida H; Kurata C
J Am Coll Cardiol; 1998 Aug; 32(2):438-43. PubMed ID: 9708473
[TBL] [Abstract][Full Text] [Related]
93. A multicenter comparison of adverse reaction profiles of isradipine and enalapril at equipotent doses in patients with essential hypertension.
Johnson BF; Eisner GM; McMahon FG; Jain AK; Rudd P; Sowers JR
J Clin Pharmacol; 1995 May; 35(5):484-92. PubMed ID: 7657848
[TBL] [Abstract][Full Text] [Related]
94. [Nicardipine, alone or in combination with enalapril, in the therapy of arterial hypertension secondary to chronic nephropathy].
Pecci G; Feriozzi S; Morabito S; Mavrikakis G; Roscia E; Simonetti BM; Pierucci A
Clin Ter; 1989 Sep; 130(6):327-32. PubMed ID: 2572374
[TBL] [Abstract][Full Text] [Related]
95. Calcium entry blockers for systemic hypertension.
Moser M
Am J Cardiol; 1987 Jan; 59(2):115A-121A. PubMed ID: 3028116
[TBL] [Abstract][Full Text] [Related]
96. Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension.
Nikkilä M; Inkovaara J; Heikkinen J
Ann Med; 1991 Apr; 23(2):141-5. PubMed ID: 2069791
[TBL] [Abstract][Full Text] [Related]
97. Sustained-release diltiazem and prevention of cardiovascular risk in hypertensive patients.
Djian J
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S20-7. PubMed ID: 1706010
[TBL] [Abstract][Full Text] [Related]
98. Cilazapril: an overview of its efficacy and safety in hypertension.
Szucs T; Schneeweiss A
Cardiology; 1992; 80(1):34-41. PubMed ID: 1532534
[TBL] [Abstract][Full Text] [Related]
99. [The efficiency of combinations of Enalapril and long-acting Nifedipin and Moxonidine in patients with arterial hypertension and a metabolic syndrome].
Mananko EI; Vorob'eva EV; Kalashnikova TP; Bushkova EA; Krasnova NM; Idrisova EM; Vengerovskiĭ AI; Karpov RS; Gruzdeva OV; Kremenko SV
Klin Med (Mosk); 2008; 86(7):56-61. PubMed ID: 18756750
[TBL] [Abstract][Full Text] [Related]
100. Synergism between alpha 1-blockade and angiotensin converting enzyme inhibition in essential hypertension.
Brown MJ; Dickerson JE
J Hypertens Suppl; 1991 Dec; 9(6):S362-3. PubMed ID: 1687874
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
